SOPITAZINE
UNII QI0U3D4X3M

Substance Identification & Data

This profile provides standardized clinical and technical data for Sopitazine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QI0U3D4X3M.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 23492-69-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

QI0U3D4X3M

CAS Registry Number

23492-69-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SOPITAZINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C20H23N3OS

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

UEIKOVSHPFMKAA-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C73012

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

210318

Unique identification number in the NCBI database of chemical substances.

INN ID

3238

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1cccc2Sc3ccccc3N(c21)C(=O)N4CCN(CC4)C(C)C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sopitazine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.